Diaphragmatic and Hiatal Hernia near Englewood Cliffs, NJ

Biography: Joshua R. Sonett MD FACS is the Edward C. and Anne K. Weiskopf Professor of Surgical Oncology (in Surgery) at CUMC, Chief of General Thoracic Surgery and Director, The Price Family Center for Comprehensive Chest Care, Lung and Esophageal Center. He is instrumental in making the Thoracic Surgery section at Columbia University Medical Center one of the best in the U.S. and he is one of the youngest professors of surgery at a major academic institution in the United States. Dr. Sonett is best known for his work on the multidisciplinary treatment of lung and esophageal malignancies. Leading work in minimally invasive treatment of lung and esophageal cancer, Dr. Sonett and his team at Columbia are innovators in the development and teaching techniques of Video Assisted Thoracic Surgery (VATS) and Minimally Invasive Esophageal (MIE) surgery, allowing surgeons to incorporate these techniques into their daily practices. Dr. Sonett and his team make up one of the few programs in the country to employ a combination of maximal chemo and radiation and surgical therapies in the treatment of locally advanced lung malignancies. He is also a leader in multi-modality therapies for lung and esophageal cancers, and a pioneer in endo-bronchial palliation of benign and malignant airway stenosis. In the clinical area of lung transplantation, Dr. Sonett is best known for developing an extended-donor lung transplant criteria protocol. Extended donor criteria (EDC) applies to the use of organs that don't meet the usual criteria for transplantation due to various health problems, but are still healthy enough for a successful transplant (Liver MD 2006). Dr. Sonett and his team have been aggressively trying to alleviate the donor shortage by evaluating lungs that may be rejected from other centers (CS News 2005). Between 2001 and 2003, 53 percent of the lungs transplanted at NewYork-Presbyterian/Columbia were extended donor criteria lungs, with no difference in survival between EDC lung recipients and regular lung recipients. The Columbia programs has a 95% survival rate after one year and 83% after three years, which far surpasses the national average of 79% and 62% respectively (CS Lung News 2006). Dr. Sonett has been an invited speaker and principal and co- investigator of numerous clinical trials, author of numerous publications in renown journals such as the Journal of The American College of Cardiology, Annals of Thoracic Surgery, and the Journal of Heart and Lung Transplant, among many others. Dr. Sonett received his MD from Brody School of Medicine at East Carolina University Medical School, and completed his surgical residency at the University of Massachusetts, and Thoracic Fellowship at the University of Pittsburgh Medical Center. Professional Memberships include the New York Thoracic Society, The Society of Thoracic Surgeons, Fellow of the American College of Surgeons and member of the American Association for Thoracic Surgeons Dr. Sonett has received numerous award and honors including annual awards to America's Top Doctors, Castle Connolly America's Top Doctors for Cancer, New York Magazine's Best Doctors, the Barbara Neibauer Celebration of Life Award, Foundation for Thymic Cancer and the Humanitarian Award, Chesed of New Square.

Biography: Dr. Ebright joined Columbia University Irving Medical Center after serving on the faculty at Boston University School of Medicine for six years. There, he was Director of the Center for Thoracic Oncology and Co-Director of the Lung CyberKnife Program. At Columbia, he sees patients for thoracic surgery and serves as Vice Chair of Surgery at Stamford Hospital, a Columbia partner site in Connecticut. He has numerous publications in peer-reviewed journals and has authored book chapters on a variety of topics related to thoracic surgery. In addition, he has been selected as a Castle Connolly Top Doctor, as identified in Boston, New York and Connecticut magazines.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Biography: Dr. Abraham Krikhely is the Chief of the Division of Minimally Invasive Surgery and Bariatric Surgery at NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Krikhely is an experienced minimally invasive surgeon specializing in robotic, laparoscopic and endoscopic approaches to metabolic and weight loss surgery, foregut surgery and general surgery. Dr. Krikhely obtained his undergraduate degree from NYU Stern School of Business and his medical degree from NYU School of Medicine. He stayed at NYU for his residency training in General Surgery, after which he completed his fellowship training in Bariatric and Minimally Invasive Surgery at Montefiore Medical Center. After building a successful practice focusing on bariatric and minimally invasive abdominal surgery as part of the full-time faculty at Maimonides Medical Center, he was recruited to join the faculty at Columbia University in 2015. He was an early proponent of robotic bariatric surgery and has also chaired the robotic surgery committee at Columbia since 2017, where he has contributed to building and growing the robotic surgery program at Columbia. He is also the program director for the Fellowship in Minimally Invasive Surgery and Bariatric Surgery at Columbia University. Dr. Krikhely has authored multiple textbook chapters on bariatric surgery, robotic surgery, and foregut surgery, given numerous lectures and proctored many surgeons on the use of robotic surgery.